Prion infection impairs copper binding of cultured cells

被引:50
作者
Rachidi, W
Mangé, A
Senator, A
Guiraud, P
Riondel, J
Benboubetra, M
Favier, A
Lehmann, S
机构
[1] CNRS, IGH, UPR 1142, F-34396 Montpellier 5, France
[2] Fac Pharm, Lab Biol Stress Oxydant, F-38706 La Tronche, France
[3] CNRS, UPR 1142, Inst Genet Humaine, F-34396 Montpellier, France
[4] CNRS, CEA, Lab Les Acides Nucleiques, F-38000 Grenoble, France
[5] Univ Setif, Fac Sci, Lab Appl Biochem, Setif 19000, Algeria
关键词
D O I
10.1074/jbc.C300092200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular mechanism of neurodegeneration in transmissible spongiform encephalopathies (TSEs) remains unclear. Using radioactive copper (Cu-64) at physiological concentration, we showed that prion infected cells display a marked reduction in copper binding. The level of full-length prion protein known to bind the metal ion was not modified in infected cells, but a fraction of this protein was not releasable from the membrane by phosphatidylinositol-specific phospholipase C. Our results suggest that prion infection modulates copper content at a cellular level and that modification of copper homeostasis plays a determinant role in the neuropathology of TSE.
引用
收藏
页码:14595 / 14598
页数:4
相关论文
共 34 条
[1]   Stimulation of PrPC retrograde transport toward the endoplasmic reticulum increases accumulation of PrPSc in prion-infected cells [J].
Béranger, F ;
Mangé, A ;
Goud, B ;
Lehmann, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (41) :38972-38977
[2]   Consequences of manganese replacement of copper for prion protein function and proteinase resistance [J].
Brown, DR ;
Hafiz, F ;
Glasssmith, LL ;
Wong, BS ;
Jones, IM ;
Clive, C ;
Haswell, SJ .
EMBO JOURNAL, 2000, 19 (06) :1180-1186
[3]   Prion and prejudice: normal protein and the synapse [J].
Brown, DR .
TRENDS IN NEUROSCIENCES, 2001, 24 (02) :85-90
[4]   Spongiform encephalopathies - B lymphocytes and neuroinvasion [J].
Brown, P .
NATURE, 1997, 390 (6661) :662-663
[5]   Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease [J].
Butterfield, DA ;
Howard, BJ ;
LaFontaine, MA .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (07) :815-828
[6]   PRION PROTEIN-BIOSYNTHESIS IN SCRAPIE-INFECTED AND UNINFECTED NEURO-BLASTOMA CELLS [J].
CAUGHEY, B ;
RACE, RE ;
ERNST, D ;
BUCHMEIER, MJ ;
CHESEBRO, B .
JOURNAL OF VIROLOGY, 1989, 63 (01) :175-181
[7]   TRUNCATED FORMS OF THE HUMAN PRION PROTEIN IN NORMAL BRAIN AND IN PRION DISEASES [J].
CHEN, SG ;
TEPLOW, DB ;
PARCHI, P ;
TELLER, JK ;
GAMBETTI, P ;
AUTILIOGAMBETTI, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :19173-19180
[8]   Neurological illness in transgenic mice expressing a prion protein with an insertional mutation [J].
Chiesa, R ;
Piccardo, P ;
Ghetti, B ;
Harris, DA .
NEURON, 1998, 21 (06) :1339-1351
[9]   Prion diseases of humans and animals: Their causes and molecular basis [J].
Collinge, J .
ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 :519-550
[10]  
Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604